Among these genes, the TP53 mutation rate of metastatic cancer was significantly higher in six different types of cancers (BLCA, CRC, NSCLC, OC, STC, and TC) but lower in HNC, compared to the primary tissue (Fig. 2A and Table 1). The gene discussed is TP53; the disease is bladder transitional cell carcinoma.